Reduce Cardio Vascular Disease risk
Conditions
Interventions
We will identify 2 work sites in Colombo district and select 10 peer mentors from the each. Every peer mentor will mentor 5 mentees.
Employees above the age of 35 years will be risk stratified into m
Moderate risk mentees will have two face to face sessions of discussion and high risk mentees will have 3 face to face sessions of discussion. At each session mentees will be provided with advice and
Sponsors
UK-Medical Research Council (MRC)/ Wellcome Trust/ Department for International Development (DFID)
Dr. Denis Xavier
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female employees above the age of 35yrs 2. Permanent employment 3. At least 6 months to retirement
Exclusion criteria
Exclusion criteria: 1. Pregnant or intent to get pregnant in one year. 2. Inability to attend follow up visits 3. Any active malignancy or known malignancy on treatment 4. Will be relocated during the study period 5. Unwilling or unable to comply with study procedures (Subject ineligible if even one criterion is met)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in knowledge attitudes & practices related to cardiovascular (CV) risk factors - assessed using Face to face interviews, questionnaires and participant diaries. [High risk group: At baseline, at the end of 1 month intervention, and at 2 month and 3 month time points (follow-up) Moderate risk group: At baseline, at the end of 1 month intervention, and at 3 months (follow-up)] Identification of barriers and facilitators for an optimal cardiovascular disease (CVD) environment at the worksites - assessed using Face to face interviews, questionnaires and participant diaries. [High risk group: At baseline, at the end of 1 month intervention, and at 2 month and 3 month time points (follow-up) Moderate risk group: At baseline, at the end of 1 month intervention, and at 3 months (follow-up] Feasibility and acceptability of the interventions to reduce CV risk - assessed using Face to face interviews, questionnaires and participant diaries. [High risk group: At baseline, at the end of 1 month intervention, and at 2 month and 3 month time points (follow-up) Moderate risk group: At baseline, at the end of 1 month intervention, and at 3 months (follow-up] Cardiovascular (CV) risk burden using a non lab based risk scoring system (Framingham Risk Score) [High risk group: At baseline, at the end of 1 month intervention, and at 2 month and 3 month time points (follow-up) Moderate risk group: At baseline, at the end of 1 month intervention, and at 3 months (follow-up] | — |
Secondary
| Measure | Time frame |
|---|---|
| Identify & train Peer Mentors to deliver an educational intervention at work sites (outcome will be measured at the end of the training programme) [At the end of the 2 day training programme ] Change in blood pressure among identified hypertensives (The study is not powered to detect this change at 3 months.) [At baseline and at the 3 month follow up point ] | — |
Countries
Sri Lanka
Contacts
Public ContactDr. Prasad Katulanda
Senior Lecturer in Medicine
Outcome results
None listed